Achillion Pharmaceuticals ACHN


Alpha BioPharma Initiates Buy On Achillion; Sees 56% Upside

In a research report released today, Alpha BioPharma’s Paul Nunzio DeSantis initiated coverage on shares of Achillion Pharmaceuticals (NASDAQ:ACHN) with a Buy rating and $16 price …